Should I Buy SURG? SURG 2026 Analysis

Should You Buy Surgepays Inc (SURG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.170

1 Day change

-5.65%

52 Week Range

3.470

Analysis Updated At

2026/01/26

SurgePays Inc (SURG) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show bearish trends, and the company's financial performance has significant weaknesses, particularly in net income and gross margin. While the recent public offering may provide capital for growth, it has also diluted the stock, and there are no strong trading signals or positive catalysts to justify immediate action.

Technical Analysis

The stock is currently in a bearish trend with MACD below zero and negatively expanding, RSI indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The pre-market price of $1.22 is below key support levels, with S1 at $1.255 and S2 at $1.021.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

The company raised $2.5 million through a public offering to support growth in the wireless and fintech sectors, which could enhance its long-term position.

Neutral/Negative Catalysts

The public offering priced below the market, leading to stock dilution. The company's financial performance shows declining net income, EPS, and gross margin. Additionally, there are no significant hedge fund or insider trading trends.

Financial Performance

In Q3 2025, revenue increased by 291.65% YoY to $18,680,317, but net income dropped by -47.54% YoY to -$7,489,068. EPS fell by -47.95% YoY to -$0.38, and gross margin declined by -91.23% YoY to -14.92%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available for SURG.

2 Analyst Rating

Wall Street analysts forecast SURG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SURG is 9.75 USD with a low forecast of 9.75 USD and a high forecast of 9.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

Current: 1.240

Low

9.75

Averages

9.75

High

9.75

Current: 1.240

Low

9.75

Averages

9.75

High

9.75

Ascendiant Capital

Edward Woo

Strong Buy

Maintains

$8.5 → $8.75

AI Analysis

2025-04-22

Reason

Ascendiant Capital

Edward Woo

Price Target

$8.5 → $8.75

AI Analysis

2025-04-22

Maintains

Strong Buy

Reason

SURG Should I Buy

SURG Should I Buy

Should You Buy Surgepays Inc (SURG) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch